SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 278 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $229,531,000 | +66.6% | 1,443,145 | +0.3% | 0.28% | +44.7% |
| Q4 2018 | $137,786,000 | -38.4% | 1,438,424 | -9.2% | 0.20% | -24.2% |
| Q3 2018 | $223,687,000 | -10.6% | 1,583,620 | -0.9% | 0.26% | -13.0% |
| Q2 2018 | $250,162,000 | -0.7% | 1,598,167 | +2.2% | 0.30% | -4.8% |
| Q1 2018 | $251,876,000 | +3.4% | 1,563,778 | +5.7% | 0.31% | +6.8% |
| Q4 2017 | $243,693,000 | +118.0% | 1,479,531 | -17.5% | 0.29% | +114.6% |
| Q3 2017 | $111,766,000 | -21.4% | 1,794,004 | +0.5% | 0.14% | -22.2% |
| Q2 2017 | $142,209,000 | +12.5% | 1,785,640 | +0.4% | 0.18% | +15.0% |
| Q1 2017 | $126,450,000 | +27.9% | 1,779,239 | -8.1% | 0.15% | +22.4% |
| Q4 2016 | $98,856,000 | +12.0% | 1,936,075 | +1.1% | 0.12% | +12.6% |
| Q3 2016 | $88,226,000 | +280.2% | 1,915,874 | +148.8% | 0.11% | +270.0% |
| Q2 2016 | $23,205,000 | -3.4% | 770,157 | +2.7% | 0.03% | -6.2% |
| Q1 2016 | $24,031,000 | – | 749,566 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |